 |
| Ball-and-stick model of the aspirin molecule, as found in the solid state. Single-crystal X-ray diffraction data from Kim, Y.; Machida, K.; Taga, T.; Osaki, K. (). "Structure Redetermination and Packing Analysis of Aspirin Crystal". Chem. Pharm. Bull. 33 (7) : 2641-2647. ISSN 1347-5223. (Photo credit: Wikipedia) |
A regular small dose of aspirin is today prescribed to heart problems. Soon cancer? Previous research has found evidence that prolonged aspirin intake, about ten years every day reduces the risk of cancer. New studies reinforce that suspicion now. And the beneficial effect appears to act quickly: after three to five years. Moreover, aspirin appears to the emergence of metastases of cancers already present to slow down. This is contained in a series of three articles published yesterday in the medical journal The Lancet . The three studies are meta-analyzes "in which existing research results are analyzed. They were led by Peter Rothwell of Oxford University. The number of cancer deaths after three years was 25 percent lower in subjects receiving aspirin than in controls. That does not mean you should start to swallow aspirin. The evidence is not foolproof (there are also large studies no beneficial effect of aspirin on cancer find) and aspirin can cause serious side effects such as stomach bleeding.
Comments